Samsung Bioepis and Teva have entered into a license, development and commercialization agreement for Epysqli ...

Approved for use by diabetics to control blood sugar, liraglutide has also evidenced an ability to slow cognitive decline in a Phase 2b clinical trial, and reduce shrinkage of those areas of the brain ...

Positive results in a recent animal study strongly supports first-ever human investigation for DehydraTECH-liraglutide in an oral capsule format KELOWNA, BC / ACCESSWIRE / January 15, 2025 / Lexaria B ...

While in 2023, there was only moderate investment in the market, 2024 marked the return of mega financing rounds, amounting ...

The increasingly fast-paced lifestyle has depleted the ordinary person’s usual diet of essential nutrients that increases the risk of atherosclerosis, despite the age group and the growth rate of ...

BFA Law Announces that a Class Action has been filed against BioAge Labs, Inc. - Contact the Firm if You Suffered Losses ...

NEW YORK, NY / ACCESSWIRE / January 14, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a ...

Teva Pharmaceutical Industries Ltd (TEVA) stock saw a decline, ending the day at $20.44 which represents a decrease of $-0.50 or -2.39% from the prior close of $20.94. The stock opened at $20.95 and ...

Ugg Since 1974's owner said it was rebranding outside Australia as it was "extremely hard fight a lawsuit against a ...

The following is a summary of “Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare Program,” ...

Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year.  | For ...

Gather's co-owner talks about his early inspiration in a Jewish environmental program and how he’s kept the restaurant ...